Times Square Capital Management, LLC Bridge Bio Pharma, Inc. Transaction History

Times Square Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	SELL	$11.38 - $53.41 $4.68 Million - $22 Million	-411,595 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$46.87 - $64.24 $868,032 - $1.19 Million	-18,520 Reduced 4.31%	411,595 $19.3 Million
Q2 2021 Aug 09, 2021	SELL	$46.47 - $63.93 $1.89 Million - $2.59 Million	-40,585 Reduced 8.62%	430,115 $26.2 Million
Q1 2021 May 12, 2021	SELL	$55.47 - $72.35 $7.55 Million - $9.84 Million	-136,060 Reduced 22.42%	470,700 $29 Million
Q4 2020 Feb 12, 2021	SELL	$38.38 - $71.11 $1.52 Million - $2.82 Million	-39,670 Reduced 6.14%	606,760 $43.1 Million
Q3 2020 Nov 06, 2020	SELL	$27.2 - $42.19 $1.96 Million - $3.05 Million	-72,199 Reduced 10.05%	646,430 $24.3 Million
Q2 2020 Aug 07, 2020	BUY	$22.22 - $35.69 $5.13 Million - $8.24 Million	230,979 Added 47.37%	718,629 $23.4 Million
Q1 2020 May 08, 2020	SELL	$16.11 - $36.23 $127,269 - $286,217	-7,900 Reduced 1.59%	487,650 $14.1 Million
Q4 2019 Feb 05, 2020	SELL	$17.96 - $46.63 $768,328 - $1.99 Million	-42,780 Reduced 7.95%	495,550 $17.4 Million
Q3 2019 Nov 05, 2019	BUY	$20.13 - $32.38 $7.82 Million - $12.6 Million	388,330 Added 258.89%	538,330 $11.6 Million
Q2 2019 Aug 02, 2019	BUY	$26.97 - $27.55 $4.05 Million - $4.13 Million	150,000 New	150,000 $4.05 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.